DAA797 |
Alveoli's ability decreases |
Physiological |
alveolus |
Human |
— |
— |
|
DAA615 |
Alzheimer's disease |
Pathological |
brain |
Human |
— |
SeriesMorbidity |
|
DAA347 |
aminolevulinate, delta-, synthase 1 |
Molecular |
skeletal muscle |
Human |
ALAS1 |
4.0% Decrease Gene Expression Level |
|
DAA2394 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
dermis |
Human |
PRKAG3 |
17.8% Decrease DNA Methylation |
|
DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
DAA2443 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
15.1% Decrease DNA Methylation |
|
DAA2395 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
dermis |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
DAA267 |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
Molecular |
kidney |
Human |
APBB1IP |
23.0% Increase Gene Expression Level |
|
DAA2100 |
anaphase promoting complex subunit 4 decreases with age |
Molecular |
ovary |
Human |
ANAPC4 |
35.5% Decrease Gene Expression Level |
|
DAA612 |
Anemia |
Pathological |
blood |
Human |
— |
SeriesMorbidity |
|
DAA2119 |
angel homolog 2 (Drosophila) decreases with age |
Molecular |
ovary |
Human |
ANGEL2 |
65.3% Decrease Gene Expression Level |
|
DAA8 |
angiomotin |
Molecular |
brain |
Human |
AMOT |
10.0% Increase Gene Expression Level |
|
DAA9 |
ankyrin 2, neuronal |
Molecular |
brain |
Human |
ANK2 |
20.0% Decrease Gene Expression Level |
|
DAA11 |
annexin A4 |
Molecular |
brain |
Human |
ANXA4 |
11.0% Increase Gene Expression Level |
|
DAA22 |
antizyme inhibitor 1 |
Molecular |
brain |
Human |
AZIN1 |
11.0% Decrease Gene Expression Level |
|
DAA629 |
Aortic aneurism and dissection |
Pathological |
aorta |
Human |
— |
SeriesMorbidity |
|
DAA680 |
Aortic pulse wave velocity increases |
Physiological |
aorta |
Human |
— |
— |
|
DAA1223 |
APOE promoter methylation decrease |
Molecular |
prefrontal cortex |
Human |
APOE |
— |
|
DAA13 |
apolipoprotein D |
Molecular |
brain |
Human |
APOD |
14.0% Increase Gene Expression Level |
|
DAA373 |
apolipoprotein O |
Molecular |
skeletal muscle |
Human |
APOO |
5.0% Decrease Gene Expression Level |
|
DAA979 |
Apoptotic pathway in response to stimuli disrupted |
Physiological |
neutrophil |
Human |
— |
— |
|
DAA2111 |
arginyl-tRNA synthetase 2, mitochondrial decreases with age |
Molecular |
ovary |
Human |
RARS2 |
48.7% Decrease Gene Expression Level |
|
DAA1202 |
arNOX specific activity increases |
Molecular |
skin |
Human |
ENOX1 |
— |
|
DAA306 |
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) |
Molecular |
skeletal muscle |
Human |
ASNA1 |
4.0% Decrease Gene Expression Level |
|
DAA679 |
Arterial rigidity gradually increases |
Physiological |
artery |
Human |
— |
— |
|